FUJIFILM Corporation announced Wednesday, Dec. 18, that it has entered into an agreement to purchase Hitachi’s diagnostic imaging business for more than $1.6 billion. AI appears to have played an important role in Fujifilm’s decision—the company will soon be able to apply its own image processing and AI capabilities to Hitachi’s own lineup of diagnostic imaging solutions.
In fact, within Fujifilm’s prepared statement on the acquisition, “providing innovation solutions by leveraging Fujifilm’s proprietary imaging processing and AI technologies” is listed as a top “intended synergy” once the deal is finalized.
“For example, the use of AI technology on CT images can reduce noise and offer better image quality in low-dose examinations,” according to the statement.
In addition, the company says this acquisition will help Fujifilm “expand into new areas, including ‘AI-supported diagnosis’ and ‘AI-supported maintenance.’
Other “intended synergies” listed in the statement were “providing one-stop total solutions” and “expanding sales capability through cross-selling.”
Fujifilm’s acquisition of Hitachi’s diagnostic imaging business is expected to be completed in July 2020. For more on the announcement, read the latest coverage from Radiology Business here and here.
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.